Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients.

Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients.

BACKGROUND: Whereas it is well established that various soluble biomarkers can predict level of liver fibrosis, their ability to predict liver-related clinical outcomes is less clearly established, in particular among HIV/viral hepatitis co-infected persons. We investigated plasma hyaluronic acid�...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Lars Peters, Amanda Mocroft, Vincent Soriano, Jürgen Rockstroh, Andri Rauch, Anders Karlsson, Brygida Knysz, Christian Pradier, Kai Zilmer, Jens D Lundgren, for EuroSIDA in EuroCoord
Format:	Artykuł
Język:	English
Wydane:	Public Library of Science (PLoS) 2013-01-01
Seria:	PLoS ONE
Dostęp online:	http://europepmc.org/articles/PMC3664579?pdf=render

Podobne zapisy

Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study.
od: Joanne Reekie, i wsp.
Wydane: (2012-01-01)

Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death.
od: Maria Casadellà, i wsp.
Wydane: (2017-01-01)

Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe.
od: Alexander Zoufaly, i wsp.
Wydane: (2014-01-01)

Long-term trends of alanine aminotransferase levels among persons living with human immunodeficiency virus/hepatitis B virus with and without hepatitis delta coinfection
od: Lorin Begré, i wsp.
Wydane: (2022-09-01)

Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America.
od: Anne Marie W Efsen, i wsp.
Wydane: (2015-01-01)

Inflammatory Process in Hepatic Encephalopathy: The Role of Interleukin-18
od: Andri Sanityoso Sulaiman
Wydane: (2018-08-01)

Hepatic encephalopathy
od: Wissam Bleibel, i wsp.
Wydane: (2012-01-01)

Hepatitis A and dengue coinfection
od: Ira shah, i wsp.
Wydane: (2015-01-01)

Acute Coinfection with Hepatitis B and Hepatitis C Viruses
od: Brian M Yan, i wsp.
Wydane: (2005-01-01)

Pathogenesis of Hepatic Encephalopathy
od: Irena Ciećko-Michalska, i wsp.
Wydane: (2012-01-01)

Management of Hepatic Encephalopathy
od: G. Wright, i wsp.
Wydane: (2011-01-01)

Minimal Hepatic Encephalopathy
od: Laura M Stinton, i wsp.
Wydane: (2013-01-01)

Hepatic Encephalopathy and Melatonin
od: Archana Arjunan, i wsp.
Wydane: (2022-04-01)

Minimum hepatic encephalopathy
od: Aggarwal Sourabh
Wydane: (2010-01-01)

Hepatic encephalopathy: An enigma
od: Rajamanickom Saranya, i wsp.
Wydane: (2013-01-01)

Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C coinfection
od: Williams, S, i wsp.
Wydane: (2014)

Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C coinfection.
od: Williams, S, i wsp.
Wydane: (2014)

Usefulness of the Stroop Test in Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy
od: Tatsunori Hanai, i wsp.
Wydane: (2021-09-01)

LATENT HEPATIC ENCEPHALOPATHY IN PATIENTS WITH MINIMUM HEPATIC FIBROSIS
od: P. O. BOGOMOLOV, i wsp.
Wydane: (2016-12-01)

Detecting spatial clusters of HIV and hepatitis coinfections.
od: Suparna Das, i wsp.
Wydane: (2018-01-01)

HIV and Hepatitis C Virus Coinfection, Cameroon
od: Christian Laurent, i wsp.
Wydane: (2007-03-01)

Characterization of hepatitis B and delta coinfection in Israel
od: Rachel Shirazi, i wsp.
Wydane: (2018-02-01)

Leprosy and hepatitis B coinfection in southern Brazil
od: Cleverson Leitão, i wsp.
Wydane: (2014-01-01)

Hepatic Encephalopathy Therapy in the ’90s
od: CN Williams
Wydane: (1994-01-01)

Hepatic Encephalopathy: A Review
od: Savan Kabaria, i wsp.
Wydane: (2021-08-01)

Emergency management of hepatic encephalopathy
od: K.L. Rodriguez-Peralta, i wsp.
Wydane: (2023-04-01)

Hepatic encephalopathy: features of pharmacotherapy
od: A. V. Polukhina, i wsp.
Wydane: (2018-04-01)

Current approaches to hepatic encephalopathy
od: Paulina Vidal-Cevallos, i wsp.
Wydane: (2022-11-01)

Diagnosis and treatment of hepatic encephalopathy
od: Ilona Savlan, i wsp.
Wydane: (2013-05-01)

Endovascular Management of Hepatic Encephalopathy
od: Hieu Le, i wsp.
Wydane: (2021-06-01)

Prediction of minimal hepatic encephalopathy
od: Sangheun Lee, i wsp.
Wydane: (2012-01-01)

Rifaximin in the treatment of hepatic encephalopathy
od: Iadevaia MD, i wsp.
Wydane: (2011-12-01)

Hepatic encephalopathy: A review
od: Javier Lizardi-Cervera, MD, i wsp.
Wydane: (2003-07-01)

The why and wherefore of hepatic encephalopathy
od: Grover VPB, i wsp.
Wydane: (2015-12-01)

Molecular aspects of hepatic encephalopathy
od: A.L. Márquez-Aguirre, i wsp.
Wydane: (2010-01-01)

Predicting overt hepatic encephalopathy after TIPS: Value of three minimal hepatic encephalopathy tests
od: Alena F. Ehrenbauer, i wsp.
Wydane: (2023-09-01)

Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?
od: Resino Salvador, i wsp.
Wydane: (2010-08-01)

Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection
od: Keeffe Emmet B, i wsp.
Wydane: (2005-09-01)

HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014.
od: Ruth Simmons, i wsp.
Wydane: (2015-01-01)

Serum zinc level in liver cirrhosis with hepatic encephalopathy and its correlation with different stages of hepatic encephalopathy
od: Divakar Kumar, i wsp.
Wydane: (2024-09-01)